Swiss Parenterals Ltd - Stock Valuation and Financial Performance

BSE: 0 | NSE: | Pharmaceuticals & Drugs | Small Cap

BSE Share Price
Not Listed

DeciZen - make an informed investing decision on Swiss Parenterals

DeciZen not available for IPO

10 Year X-Ray of Swiss Parenterals:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.

Value Creation

Value Creation Index Colour Code Guide

Mar'13Mar'14Mar'15Mar'16Mar'17TTM
ROCE % 13.6%13%6.1%11.4%19%-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 40.74748.448.356.757
Sales YoY Gr.-15.7%2.8%-0.1%17.4%-
Adj EPS 86.11.23.38.78.8
YoY Gr.--23.9%-80.7%180.3%164.3%-
BVPS (₹) 26.331.933.1044.945.6
Adj Net
Profit
3.83.40.72.46.46
Cash Flow from Ops. 2.87.73.96.13.6-
Debt/CF from Ops. 6.51.94.504.2-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales NANA6.4%17.4%
Adj EPS NANA12.6%164.3%
BVPSNANA12.1%NA
Share Price - - - -

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'13Mar'14Mar'15Mar'16Mar'17TTM
Return on
Equity %
28.621.83.610.621.119.4
Op. Profit
Mgn %
17.315.11417.924.5NAN
Net Profit
Mgn %
9.37.21.4511.311.4
Debt to
Equity
1.60.8100.5-
Working Cap
Days
016218196990
Cash Conv.
Cycle
0154552540

Recent Performance Summary

Login to view analysis.
Login to view analysis.

Latest Financials - Swiss Parenterals Ltd.

Standalone Consolidated
TTM EPS (₹) 8.8 -
TTM Sales (₹ Cr.) 56.7 -
BVPS (₹.) 45.6 -
Reserves (₹ Cr.) 26 -
P/BV 0.00 -
PE 0.00 -
From the Market
52 Week Low / High (₹) 0.00 / 0.00
All Time Low / High (₹) - / -
Market Cap (₹ Cr.) 0
Equity (₹ Cr.) 7.4
Face Value (₹) 10
Industry PE 48.1

Management X-Ray of Swiss Parenterals:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.00
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Swiss Parenterals

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'13Mar'14Mar'15Mar'16Mar'17
Sales40.6647.0348.3548.2956.69
Operating Expenses 33.6540.1241.5939.6442.82
Manufacturing Costs9.1810.9411.859.8413.55
Material Costs19.5123.4122.3120.5419.24
Employee Cost 1.292.132.812.983.96
Other Costs 3.673.634.616.286.07
Operating Profit 7.016.916.768.6513.87
Operating Profit Margin (%) 17.2%14.7%14.0%17.9%24.5%
Other Income 0.210.340.330.680.71
Interest 0.701.112.071.691.19
Depreciation 0.601.273.923.583.11
Exceptional Items -0.16-0.15000
Profit Before Tax 5.774.721.114.0610.28
Tax 2.041.580.391.433.81
Profit After Tax 3.723.150.722.636.46
PAT Margin (%) 9.2%6.7%1.5%5.4%11.4%
Adjusted EPS (₹)7.85.71.30.08.8
Dividend Payout Ratio (%)0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'13Mar'14Mar'15Mar'16Mar'17

Equity and Liabilities

Shareholders Fund 12.4717.7718.4527.0733.59
Share Capital 1.061.241.241.647.37
Reserves 11.4216.5317.2125.4326.21
Minority Interest00000
Debt16.1914.7917.478.2115.37
Long Term Debt12.5410.3811.295.896.15
Short Term Debt3.654.416.182.329.22
Trade Payables9.4210.8311.948.8310.59
Others Liabilities 9.224.0711.136.018.03
Total Liabilities 47.3147.4658.9850.1267.57

Fixed Assets

Gross Block9.1630.4832.9433.5234.47
Accumulated Depreciation3.985.119.0812.6315.54
Net Fixed Assets5.1825.3723.8620.8918.92
CWIP 14.850.260.1804.21
Investments 00000
Inventories11.037.749.957.498.76
Trade Receivables6.436.3514.989.9119.09
Cash Equivalents 2.331.944.214.897.13
Others Assets7.495.805.806.949.46
Total Assets 47.3147.4658.9850.1267.57

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'13Mar'14Mar'15Mar'16Mar'17
Cash Flow From Operating Activity 2.837.683.906.103.63
PBT 5.774.721.114.0610.28
Adjustment 1.232.325.984.994.02
Changes in Working Capital -2.121.74-2.43-1.22-6.61
Tax Paid -2.06-1.10-0.76-1.73-4.06
Cash Flow From Investing Activity -12.43-6.93-2.24-0.48-7.37
Capex -13.10-6.87-2.39-0.74-5.01
Net Investments 00000
Others 0.67-0.060.150.27-2.36
Cash Flow From Financing Activity 10.74-1.150.61-4.955.97
Net Proceeds from Shares 1.441.36060
Net Proceeds from Borrowing 8.74-2.160.91-5.400.27
Interest Paid -0.70-1.11-2.07-1.69-1.19
Dividend Paid 00000
Others 1.260.751.77-3.866.90
Net Cash Flow 1.14-0.392.270.682.23
PARTICULARSMar'13Mar'14Mar'15Mar'16Mar'17
Ratios
ROE (%)33.1721.713.9911.5421.48
ROCE (%)21.3818.559.2616.127.36
Asset Turnover Ratio0.881.040.960.921.02
PAT to CFO Conversion(x)0.762.445.422.320.56
Working Capital Days
Receivable Days5647769088
Inventory Days9670636350
Payable Days176158186185184

Swiss Parenterals Ltd Stock News

Swiss Parenterals Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Swiss Parenterals on 01-Jan-1970 05:30 is ₹0.00.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 01-Jan-1970 05:30 the market cap of Swiss Parenterals stood at ₹0.00.
The latest P/E ratio of Swiss Parenterals as of 01-Jan-1970 05:30 is 0.00.
The latest P/B ratio of Swiss Parenterals as of 01-Jan-1970 05:30 is 0.00.
The 52-week high of Swiss Parenterals is ₹0.00 and the 52-week low is ₹0.00.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Swiss Parenterals is ₹56.69 ( Cr.) .

About Swiss Parenterals Ltd

No data to display
To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.